Tag: multiparametric MRI

Recent long-term data reveal that active surveillance can offer high prostate cancer-specific survival when paired with advanced monitoring tools like multiparametric MRI and biomarkers. Experts emphasize the importance of a proactive, technology-driven approach to achieve the best treatment-free survival. keep reading

UPDATE: 11/21/2025 Originally published Mar. 11, 2024 The blog below announced news that before radical prostatectomy (RP), multiparametric MRI findings can predict if a prostate cancer (PCa) patient is at risk of recurrence after RP. Prior to MRI predictions, the CAPRA-S score had become the gold standard for predicting biochemical recurrence risk—but only after the surgery was done. Thus, keep reading

Australia is rethinking prostate cancer screening, proposing annual PSA testing, earlier screenings for high-risk men, and the integration of mpMRI to improve detection. The reforms aim to address past guideline shortcomings and reduce late-stage diagnoses. keep reading

Recent studies are questioning whether prostatectomies can sometimes proceed without a prior biopsy, thanks to high-precision imaging techniques like mpMRI and PSMA PET scans. While this approach offers some benefits, including fewer procedural risks, it sparks important debates about accuracy, patient safety, and treatment planning. keep reading

Some men avoid doctor visits and underestimate their risk, but skipping annual check-ups can mean missing early prostate cancer. New advances like MRI can help avoid unnecessary biopsies and find cancer when it's most treatable. keep reading

Emerging research reveals that early PSA after radiation and androgen deprivation therapy can help predict prostate cancer outcomes. Meanwhile, a new genomic test is showing potential for identifying which patients face higher risk of long-term urinary side effects. keep reading

Long waits for a prostate MRI can cause anxiety and delay treatment decisions. A new AI tool is designed to help doctors quickly identify which patients need scans most urgently, so they don’t lose valuable time in their cancer care journey. keep reading

Did you know over 95% of prostate cancers share the same name—adenocarcinoma? This common cell type is usually slow-growing, but not always. Understanding how it develops, why PSA levels matter, and what early detection can reveal is key to knowing your best treatment options. keep reading

Focal therapy is gaining popularity among urologists, offering men with prostate cancer a targeted treatment that helps preserve quality of life. As more doctors adopt this approach, advanced imaging like mpMRI is ensuring greater precision and better results. keep reading

What if prostate cancer treatment didn’t mean choosing between surgery, radiation, or living with uncertainty? Focal therapy, guided by MRI, targets only the cancer while sparing healthy tissue, helping men avoid the “gray area blues” with confidence and peace of mind. keep reading